Related references
Note: Only part of the references are listed.Molecular subtyping of cancer: current status and moving toward clinical applications
Lan Zhao et al.
BRIEFINGS IN BIOINFORMATICS (2019)
Genomic Analysis in the Age of Human Genome Sequencing
Tuuli Lappalainen et al.
CELL (2019)
Anti-FIRΔexon2, a splicing variant form of PUF60, autoantibody is detected in the sera of esophageal squamous cell carcinoma
Sohei Kobayashi et al.
CANCER SCIENCE (2019)
Urinary Cell-Free DNA IQGAP3/BMP4 Ratio as a Prognostic Marker for Non-Muscle-Invasive Bladder Cancer
Yanjie Xu et al.
CLINICAL GENITOURINARY CANCER (2019)
Four novel biomarkers for bladder cancer identified by weighted gene coexpression network analysis
Xin Yan et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
DNA topoisomerase IIα and RAD21 cohesin complex component are predicted as potential therapeutic targets in bladder cancer
Zhiling Yu et al.
ONCOLOGY LETTERS (2019)
Pervasive Chromatin-RNA Binding Protein Interactions Enable RNA-Based Regulation of Transcription
Rui Xiao et al.
CELL (2019)
Alternative cleavage and polyadenylation in health and disease
Andreas J. Gruber et al.
NATURE REVIEWS GENETICS (2019)
Diagnostic value of combined IQGAP3/BMP4 and IQGAP3/FAM107A expression ratios in urinary cell-free DNA for discriminating bladder cancer from hematuria
Yanjie Xu et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2019)
PUF60 accelerates the progression of breast cancer through downregulation of PTEN expression
Dongying Sun et al.
CANCER MANAGEMENT AND RESEARCH (2019)
The prevalence and clinical significance of anti-PUF60 antibodies in patients with idiopathic inflammatory myopathy
Ya-Mei Zhang et al.
CLINICAL RHEUMATOLOGY (2018)
Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers
Gladell P. Paner et al.
EUROPEAN UROLOGY (2018)
PUF60-activated exons uncover altered 3′ splice-site selection by germline missense mutations in a single RRM
Jana Kralovicova et al.
NUCLEIC ACIDS RESEARCH (2018)
TACC3 transcriptionally upregulates E2F1 to promote cell growth and confer sensitivity to cisplatin in bladder cancer
Zhi-Rui Lin et al.
CELL DEATH & DISEASE (2018)
Disturbed alternative splicing of FIR (PUF60) directed cyclin E overexpression in esophageal cancers
Yukiko Ogura et al.
Oncotarget (2018)
Urinary cell-free nucleic acid IQGAP3: a new non-invasive diagnostic marker for bladder cancer
Won Tae Kim et al.
Oncotarget (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Increased AURKA promotes cell proliferation and predicts poor prognosis in bladder cancer
Mengjie Guo et al.
BMC SYSTEMS BIOLOGY (2018)
Exome sequencing reveals NAA15 and PUF60 as candidate genes associated with intellectual disability
Jin J. Zhao et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2018)
Dominant variants in the splicing factor PUF60 cause a recognizable syndrome with intellectual disability, heart defects and short stature
Salima El Chehadeh et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2017)
PUF60 variants cause a syndrome of ID, short stature, microcephaly, coloboma, craniofacial, cardiac, renal and spinal features
Karen J. Low et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2017)
Aurora A Kinase Is a Priority Pharmaceutical Target for the Treatment of Cancers
Arun Prasath Damodaran et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
Aurora Kinase A is a Biomarker for Bladder Cancer Detection and Contributes to its Aggressive Behavior
Aaron Mobley et al.
SCIENTIFIC REPORTS (2017)
Identification of Biomarkers Correlated with the TNM Staging and Overall Survival of Patients with Bladder Cancer
Sheng Li et al.
FRONTIERS IN PHYSIOLOGY (2017)
Bladder cancer
Oner Sanli et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
IFI16 restoration in hepatocellular carcinoma induces tumour inhibition via activation of p53 signals and inflammasome
Wei Lin et al.
CELL PROLIFERATION (2017)
MicroRNA-124-3p affects proliferation, migration and apoptosis of bladder cancer cells through targeting AURKA
Qiuyue Yuan et al.
CANCER BIOMARKERS (2017)
Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes
A. Sveen et al.
ONCOGENE (2016)
IFI16, an amplifier of DNA-damage response: Role in cellular senescence and aging-associated inflammatory diseases
Divaker Choubey et al.
AGEING RESEARCH REVIEWS (2016)
Physiologic Expression of Sf3b1K700E Causes Impaired Erythropoiesis, Aberrant Splicing, and Sensitivity to Therapeutic Spliceosome Modulation
Esther A. Obeng et al.
CANCER CELL (2016)
Aurora-A Kinase: A Potent Oncogene and Target for Cancer Therapy
Min Yan et al.
MEDICINAL RESEARCH REVIEWS (2016)
Altered RECQL5 expression in urothelial bladder carcinoma increases cellular proliferation and makes RECQL5 helicase activity a novel target for chemotherapy
Karl Patterson et al.
ONCOTARGET (2016)
Anti-FIRs (PUF60) auto-antibodies are detected in the sera of early-stage colon cancer patients
Sohei Kobayashi et al.
ONCOTARGET (2016)
Helicobacter pylori Infection Is Associated with Decreased Expression of SLC5A8, a Cancer Suppressor Gene, in Young Children
Andrea Orellana-Manzano et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2016)
Bladder Cancer Molecular Taxonomy: Summary from a Consensus Meeting
Seth P. Lerner et al.
BLADDER CANCER (2016)
RNA splicing factors as oncoproteins and tumour suppressors
Heidi Dvinge et al.
NATURE REVIEWS CANCER (2016)
Slc5a8, a Na+-coupled high-affinity transporter for short-chain fatty acids, is a conditional tumour suppressor in colon that protects against colitis and colon cancer under low-fibre dietary conditions
Ashish Gurav et al.
BIOCHEMICAL JOURNAL (2015)
Mutant U2AF1 Expression Alters Hematopoiesis and Pre-mRNA Splicing In Vivo
Cara Lunn Shirai et al.
CANCER CELL (2015)
On Molecular Classification of Bladder Cancer: Out of One, Many
Mattias Aine et al.
EUROPEAN UROLOGY (2015)
Concomitant expression of far upstream element (FUSE) binding protein (FBP) interacting repressor (FIR) and its splice variants induce migration and invasion of non-small cell lung cancer (NSCLC) cells
Benedikt Mueller et al.
JOURNAL OF PATHOLOGY (2015)
Muscle-invasive bladder cancer is characterized by overexpression of thymidine kinase 1
Steffen Rausch et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2015)
Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndrome
Vikas Madan et al.
NATURE COMMUNICATIONS (2015)
Overexpression of Far Upstream Element (FUSE) Binding Protein (FBP)-Interacting Repressor (FIR) Supports Growth of Hepatocellular Carcinoma
Mona Malz et al.
HEPATOLOGY (2014)
The plasma membrane transporter SLC5A8 suppresses tumour progression through depletion of survivin without involving its transport function
Veena Coothankandaswamy et al.
BIOCHEMICAL JOURNAL (2013)
SAP155-mediated c-myc suppressor far-upstream element-binding protein-interacting repressor splicing variants are activated in colon cancer tissues
Toshiko Kajiwara et al.
CANCER SCIENCE (2013)
The Investigational Aurora Kinase A Inhibitor MLN8237 Induces Defects in Cell Viability and Cell-Cycle Progression in Malignant Bladder Cancer Cells In Vitro and In Vivo
Ning Zhou et al.
CLINICAL CANCER RESEARCH (2013)
Regulation of constitutive and alternative splicing by PRMT5 reveals a role for Mdm4 pre-mRNA in sensing defects in the spliceosomal machinery
Marco Bezzi et al.
GENES & DEVELOPMENT (2013)
Molecular Mechanism of SLC5A8 Inactivation in Breast Cancer
Selvakumar Elangovan et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
High expression of spindle assembly checkpoint proteins CDC20 and MAD2 is associated with poor prognosis in urothelial bladder cancer
Jung-Woo Choi et al.
VIRCHOWS ARCHIV (2013)
SLC5A8 Nuclear Translocation and Loss of Expression are Associated With Poor Outcome in Pancreatic Ductal Adenocarcinoma
James Helm et al.
PANCREAS (2012)
Evolution of SR protein and hnRNP splicing regulatory factors
Anke Busch et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2012)
Role of SLC5A8, a plasma membrane transporter and a tumor suppressor, in the antitumor activity of dichloroacetate
E. Babu et al.
ONCOGENE (2011)
Understanding splicing regulation through RNA splicing maps
Joshua T. Witten et al.
TRENDS IN GENETICS (2011)
Shared and separate functions of polo-like kinases and aurora kinases in cancer
Susanne M. A. Lens et al.
NATURE REVIEWS CANCER (2010)
DNA hypermethylation and epigenetic silencing of the tumor suppressor gene, SLC5A8, in acute myeloid leukemia with the MLL partial tandem duplication
Susan P. Whitman et al.
BLOOD (2008)
Update on Aurora Kinase Inhibitors in Gynecologic Malignancies
Xia Tao et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2008)
CDC20, a potential cancer therapeutic target, is negatively regulated by p53
T. Kidokoro et al.
ONCOGENE (2008)
Increased SKP2 and CKS1 gene expression contributes to the progression of human urothelial carcinoma
Kazumori Kawakami et al.
JOURNAL OF UROLOGY (2007)
SLC5A8 triggers tumor cell apoptosis through pyruvate-dependent inhibition of histone deacetylases
Muthusamy Thangaraju et al.
CANCER RESEARCH (2006)
An essential role of alternative splicing of c-myc suppressor FUSE-binding protein-interacting repressor in carcinogenesis
K Matsushita et al.
CANCER RESEARCH (2006)
PTX1(ERGIC2)-VP22 fusion protein upregulates interferon-beta in prostate cancer cell line PC-3
Simon C. M. Kwok et al.
DNA AND CELL BIOLOGY (2006)
The role of potential splicing factors including RBMY, RBMX, hnRNPG-T and STAR proteins in spermatogenesis
DJ Elliott
INTERNATIONAL JOURNAL OF ANDROLOGY (2004)
The cellular geography of aurora kinases
M Carmena et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers
H Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Effects of PTX1 expression on growth and tumorigenicity of the prostate cancer cell line PC-3
XH Liu et al.
DNA AND CELL BIOLOGY (2003)
Prognostic value of MCM2 immunoreactivity in StageT1 transitional cell carcinoma of the bladder
S Krüger et al.
EUROPEAN UROLOGY (2003)
Molecular cloning, expression, localization, and gene organization of PTX1, a human nuclear protein that is downregulated in prostate cancer
SCM Kwok et al.
DNA AND CELL BIOLOGY (2001)
The FBP interacting repressor targets TFIIH to inhibit activated transcription
JH Liu et al.
MOLECULAR CELL (2000)
Share Paper
